Equipmake Holdings - Board Changes & Appointment of new CFO
Announcement provided by
Equipmake Holdings PLC · EQIP22/04/2024 07:00
22 April 2024
Equipmake Holdings plc
("Equipmake" or the "Company")
Board Changes & Appointment of new Chief Financial Officer
Equipmake, the
Tony will be based at the Group's
Tony has extensive senior financial experience gained in a number of ambitious high growth technology companies on public markets, including both AIM and Nasdaq. This experience extends across a number of sectors, including healthcare, software and materials science. Most recently, as CFO of SourceBio International, he contributed to a fourfold increase in revenues over a two-year period, whilst significantly strengthening the balance sheet and leading its AIM IPO, raising
In prior CFO roles, Tony has acquired varied operational, transactional, and strategic experience and driven significant growth, both organically and via M&A, with an ultimate focus on creating value for shareholders.
Ian Foley, CEO of Equipmake, commented: "I am delighted to announce Tony's appointment as Chief Financial Officer. He brings over two decades of experience in fast growing international companies. Tony also has a wealth of experience working within publicly listed companies and provides a valuable additional perspective as Equipmake pursues its future opportunities and business growth.
"Combined with the recent appointment of Nick Moelders as Chief Operating Officer, Tony's appointment further strengthens our Board as we grow our market presence and increase our impact as a rapidly scaling, global electrification technology company, with a growing roster of customers.
"I would also like to use this opportunity to thank Steve for his dedication and service to Equipmake over the last three years. Steve has helped to steer Equipmake through what has been a transformational period for the Company. I would like to wish him the very best in the future."
Disclosures required pursuant to Rule 4.9 of the Aquis Growth Market Apex Rulebook
Tony Ratcliffe has the following current and previous directorships, over the last five years, to declare. He does not hold any securities issued by the Company.
Current directorships
|
Former directorships, within the last five years |
Consilium Financial Limited
|
SourceBio International Limited (formerly SourceBio International plc) Source BioScience Inc Source BioScience Ireland Limited Source BioScience (Storage) Limited Source Bioscience Source BioScience (Healthcare) Limited Select Pharma Laboratories Limited Source BioScience (Orchard Place) Limited Source BioScience (Cryobank) Limited Geneservice Limited Fairfield Imaging Limited Fairfield Telepathology Limited Kinetic Imaging Limited Cryobank Guarantor Limited Source BioScience Scotland Limited LDPath Limited SourceBio International Inc Source Genomics Limited Metalysis Limited* High Entropy Alloys Limited Metalysis High Entropy Alloys Limited Metalysis Malaysia Sdn Bhd Metalysis Titanium Limited
|
*Tony was, until 1 March 2020, a director of Metalysis Limited, which was put into administration on 3 June 2019. Following the sale of assets, the process of administration was subsequently completed on 9 June 2021, with unsatisfied creditors amounting to c.
Save as set out in this announcement, Tony Ratcliffe has confirmed there are no further details to be disclosed in connection with his appointment as a director of the Company pursuant to Rule 4.9 of the Aquis Growth Market Apex Rulebook.
For further information, please contact:
Equipmake Ian Foley, Founder and CEO
|
Via St Brides Partners |
Panmure Gordon (Corporate Adviser & Joint Broker) James Sinclair-Ford / Freddie Twist / Joseph Tan Hugh Rich / Sam Elder
|
Tel: +44 (0) 20 7886 2500
|
VSA Capital Limited (Joint Broker) Simon Barton / Simba Khatai / Alex Cabral
|
Tel: +44 (0) 20 3005 5000 |
St Brides Partners (Financial PR Adviser) Susie Geliher / Paul Dulieu
|
Tel: +44 (0) 20 7236 1177 |
About Equipmake
Equipmake is the
Equipmake produces ultra-high performance electric motors and complete EV drivetrains and ultra-fast power electronic systems. As well as developing proprietary technology - such as an ultra-compact, lightweight high performance spoke motor - it also offers bespoke R&D solutions.
Equipmake has developed a vertically integrated solution providing fully bespoke solutions. The Company has built a significant pipeline of opportunities, as demand for electric vehicles increases as part of the global decarbonisation movement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.